| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Sep 12, 2025 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -659 | -1.13% | ✗ | $28.4K |
| Jun 18, 2025 | Jun 20, 2025 | Akero Therapeutics, Inc. | CFO | Sell | 42.5 | -1,634 | -2.76% | ✗ | $89.6K |
| Jun 10, 2025 | Jun 12, 2025 | Akero Therapeutics, Inc. | CFO | Sell | 42.5 | -2,804 | -4.53% | ✗ | $151.4K |
| Mar 12, 2025 | Mar 14, 2025 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -676 | -1.08% | ✗ | $30.3K |
| Dec 10, 2024 | Dec 12, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 42.5 | -2,817 | -6.85% | ✗ | $86.7K |
| Dec 2, 2024 | Dec 4, 2024 | Disc Medicine, Inc. | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $126.5K |
| Nov 1, 2024 | Nov 5, 2024 | Disc Medicine, Inc. | Director | Sell | 7.5 | -7,337 | -57.27% | ✓ | $427.5K |
| Oct 1, 2024 | Oct 3, 2024 | Disc Medicine, Inc. | Director | Sell | 13.8 | -201 | -100.00% | ✓ | $10.3K |
| Sep 10, 2024 | Sep 13, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -639 | -1.53% | ✗ | $16.7K |
| Sep 3, 2024 | Sep 5, 2024 | Disc Medicine, Inc. | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $97.2K |
| Aug 26, 2024 | Aug 29, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 5.0 | -98,334 | -37.04% | ✓ | $2.7M |
| Aug 1, 2024 | Aug 5, 2024 | Disc Medicine, Inc. | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $8.7K |
| Jul 23, 2024 | Jul 25, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 5.0 | -161,855 | -34.38% | ✓ | $4.4M |
| Jul 16, 2024 | Jul 18, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 7.5 | -34,811 | -45.44% | ✓ | $976.3K |
| Jul 1, 2024 | Jul 3, 2024 | Disc Medicine, Inc. | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $9.3K |
| Jun 11, 2024 | Jun 13, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 42.5 | -2,831 | -5.70% | ✗ | $64.1K |
| Jun 3, 2024 | Jun 5, 2024 | Disc Medicine, Inc. | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $70.6K |
| May 1, 2024 | May 3, 2024 | Disc Medicine, Inc. | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $5.8K |
| Apr 11, 2024 | Apr 15, 2024 | Disc Medicine, Inc. | Director | Sell | 10.0 | -2,560 | -100.00% | ✓ | $81.4K |
| Mar 13, 2024 | Mar 15, 2024 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -724 | -1.44% | ✗ | $20.5K |
| Dec 14, 2023 | Dec 18, 2023 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -611 | -1.20% | ✗ | $12.7K |
| Dec 12, 2023 | Dec 14, 2023 | Disc Medicine, Inc. | Director | Sell | 17.5 | -33,511 | -100.00% | ✗ | $2.1M |
| Sep 13, 2023 | Sep 25, 2023 | Akero Therapeutics, Inc. | CFO | Sell | 41.3 | -632 | -3.31% | ✓ | $31.8K |
| Jun 20, 2023 | Jun 22, 2023 | Akero Therapeutics, Inc. | CFO | Sell | 17.5 | -20,777 | -52.10% | ✗ | $1.1M |
| Jun 13, 2023 | Jun 15, 2023 | Akero Therapeutics, Inc. | CFO | Sell | 45.0 | -606 | -2.64% | ✓ | $33.4K |
| Mar 10, 2023 | Mar 14, 2023 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -641 | -2.71% | ✗ | $27.9K |
| Jan 23, 2023 | Jan 24, 2023 | Ventyx Biosciences, Inc. | Director | Sell | 5.0 | -33,353 | -100.00% | ✓ | $1.2M |
| Dec 27, 2022 | Dec 29, 2022 | Akero Therapeutics, Inc. | CFO | Sell | 7.5 | -20,000 | -29.74% | ✓ | $995.3K |
| Oct 13, 2022 | Oct 17, 2022 | Akero Therapeutics, Inc. | CFO | Sell | 7.5 | -20,000 | -81.87% | ✓ | $796.4K |
| Sep 13, 2022 | Sep 15, 2022 | Akero Therapeutics, Inc. | CFO | Sell | 7.5 | -32,500 | -88.01% | ✓ | $878.3K |
| Jan 14, 2022 | Jan 18, 2022 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -9,700 | -74.75% | ✓ | $213.7K |
| Dec 21, 2021 | Dec 23, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 46.3 | -100 | -2.96% | ✓ | $2.2K |
| Dec 17, 2021 | Dec 20, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -3,200 | -49.41% | ✓ | $70.5K |
| Nov 1, 2021 | Nov 3, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -6,500 | -66.48% | ✓ | $144.6K |
| Oct 1, 2021 | Oct 5, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -6,500 | -66.48% | ✓ | $143.4K |
| Sep 1, 2021 | Sep 3, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -8,559 | -72.31% | ✓ | $205.4K |
| Aug 2, 2021 | Aug 4, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -4,441 | -57.54% | ✓ | $97.8K |
| Jul 6, 2021 | Jul 8, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -6,500 | -66.48% | ✓ | $159.4K |
| May 3, 2021 | May 4, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 10.0 | -4,200 | -64.91% | ✓ | $128.4K |
| Apr 1, 2021 | Apr 5, 2021 | Akero Therapeutics, Inc. | CFO | Sell | 5.0 | -50,000 | -95.66% | ✓ | $1.4M |